acid

(redirected from Aminocaproic acid)
Also found in: Dictionary, Medical, Legal, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • adj
  • noun
  • phrase

Synonyms for acid

Synonyms for acid

Synonyms for acid

any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt

being sour to the taste

Related Words

having the characteristics of an acid

References in periodicals archive ?
05) davali transfuzvon (empirik) aPTT--Aktive parsiyal tromboplastin zamani, EACA--Epsilon aminocaproic acid, ES--Eritrosit suspansiyonu, INR--International normalized ratio, KABC--Koroner arter baypas cerrahisi, POC--Point of care, PT--Protrombin zamani, TEG--Tromboelastografi, TDP--Taze donmus plazma Tablo 4.
The 13th edition of the AABB Technical Manual lists a procedure for the treatment of incompletely clotted specimens using thrombin, 1-percent protamine sulfate, glass beads, and epsilon aminocaproic acid (EACA), which may be useful if testing facilities are still using clot tubes rather than EDTA.
Until its permanent withdrawal from the market in 2008, the antifibrinolytic Trasylol (aprotinin) had been shown in a number of studies to be more effective at reducing blood loss than the other two commonly used agents, tranexamic acid (TXA) and epsilon aminocaproic acid (EACA).
To investigate their effect on the nonspecific binding, the following proteins and compounds were attached to the nanoparticles, one at a time: Mab H50, bovine serum albumin, casein, milk powder, aminocaproic acid, glycine, and ethanolamine.
5 mmol of benzamidine, and 50 mmol of aminocaproic acid.
This action follows notification to Bayer and regulatory authorities that the BART Executive Committee had halted the trial after a planned periodic data analysis indicated reduced bleeding but also an increase in all-cause mortality (that almost reached conventional statistical significance for 30- day mortality) for patients in the aprotinin treatment arm compared to patients who received either aminocaproic acid or tranexamic acid.
This followed a letter from the BART Data Safety Monitoring Board informing the Committee that a planned periodic data analysis indicated reduced bleeding but also an increase in all-cause mortality (that almost reached conventional statistical significance for 30-day mortality) for patients in the aprotinin treatment arm compared to patients who received either aminocaproic acid or tranexamic acid.